These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2023244)

  • 1. Crystallization of the B chain of Shiga-like toxin I from Escherichia coli.
    Hart PJ; Monzingo AF; Donohue-Rolfe A; Keusch GT; Calderwood SB; Robertus JD
    J Mol Biol; 1991 Apr; 218(4):691-4. PubMed ID: 2023244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli.
    Stein PE; Boodhoo A; Tyrrell GJ; Brunton JL; Read RJ
    Nature; 1992 Feb; 355(6362):748-50. PubMed ID: 1741063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3.
    Ling H; Boodhoo A; Hazes B; Cummings MD; Armstrong GD; Brunton JL; Read RJ
    Biochemistry; 1998 Feb; 37(7):1777-88. PubMed ID: 9485303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mutant Shiga-like toxin IIe bound to its receptor Gb(3): structure of a group II Shiga-like toxin with altered binding specificity.
    Ling H; Pannu NS; Boodhoo A; Armstrong GD; Clark CG; Brunton JL; Read RJ
    Structure; 2000 Mar; 8(3):253-64. PubMed ID: 10745005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of three amino acid residues in the B subunit of Shiga toxin and Shiga-like toxin type II that are essential for holotoxin activity.
    Perera LP; Samuel JE; Holmes RK; O'Brien AD
    J Bacteriol; 1991 Feb; 173(3):1151-60. PubMed ID: 1991714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli.
    Calderwood SB; Auclair F; Donohue-Rolfe A; Keusch GT; Mekalanos JJ
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4364-8. PubMed ID: 3299365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine.
    Weinstein DL; Jackson MP; Samuel JE; Holmes RK; O'Brien AD
    J Bacteriol; 1988 Sep; 170(9):4223-30. PubMed ID: 3045088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallization and preliminary X-ray crystallographic analysis of verotoxin-1 B-subunit.
    Boodhoo A; Read RJ; Brunton J
    J Mol Biol; 1991 Oct; 221(3):729-31. PubMed ID: 1942026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription of the Shiga-like toxin type II and Shiga-like toxin type II variant operons of Escherichia coli.
    Sung LM; Jackson MP; O'Brien AD; Holmes RK
    J Bacteriol; 1990 Nov; 172(11):6386-95. PubMed ID: 2228965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands.
    Kitov PI; Sadowska JM; Mulvey G; Armstrong GD; Ling H; Pannu NS; Read RJ; Bundle DR
    Nature; 2000 Feb; 403(6770):669-72. PubMed ID: 10688205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of recombinant shiga-like toxin type I B subunit.
    Austin PR; Hovde CJ
    Protein Expr Purif; 1995 Dec; 6(6):771-9. PubMed ID: 8746629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystallization of the C-terminal domain of the addiction antidote CcdA in complex with its toxin CcdB.
    Buts L; De Jonge N; Loris R; Wyns L; Dao-Thi MH
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Oct; 61(Pt 10):949-52. PubMed ID: 16511204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I.
    Hovde CJ; Calderwood SB; Mekalanos JJ; Collier RJ
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2568-72. PubMed ID: 3357883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that the A2 fragment of Shiga-like toxin type I is required for holotoxin integrity.
    Austin PR; Jablonski PE; Bohach GA; Dunker AK; Hovde CJ
    Infect Immun; 1994 May; 62(5):1768-75. PubMed ID: 8168939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Shiga-like toxin in Escherichia coli strains, etiological agents of diarrheal disease.
    Meitert T; Tonciu M; Ciudin L; Pencu E; Mihai I; Nicolescu S
    Arch Roum Pathol Exp Microbiol; 1989; 48(4):293-8. PubMed ID: 2520669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotyping of Shiga-like toxin genes in non-O157 Escherichia coli strains associated with haemolytic uraemic syndrome.
    Rüssmann H; Kothe E; Schmidt H; Franke S; Harmsen D; Caprioli A; Karch H
    J Med Microbiol; 1995 Jun; 42(6):404-10. PubMed ID: 7791204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of tyrosine-114 in the enzymatic activity of the Shiga-like toxin I A-chain.
    Deresiewicz RL; Austin PR; Hovde CJ
    Mol Gen Genet; 1993 Nov; 241(3-4):467-73. PubMed ID: 8246901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly conserved B-subunit genes of Shiga-like toxin II variants found in Escherichia coli O157 strains.
    Rüssmann H; Schmidt H; Caprioli A; Karch H
    FEMS Microbiol Lett; 1994 May; 118(3):335-40. PubMed ID: 8020756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallization and preliminary X-ray diffraction studies of alpha-toxin from two different strains (NCTC8237 and CER89L43) of Clostridium perfringens.
    Basak AK; Howells A; Eaton JT; Moss DS; Naylor CE; Miller J; Titball RW
    Acta Crystallogr D Biol Crystallogr; 1998 Nov; 54(Pt 6 Pt 2):1425-8. PubMed ID: 10089527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of the Shiga toxin and Shiga-like toxin type II variant binding subunits by using site-directed mutagenesis.
    Jackson MP; Wadolkowski EA; Weinstein DL; Holmes RK; O'Brien AD
    J Bacteriol; 1990 Feb; 172(2):653-8. PubMed ID: 2404947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.